RxDoctor Payments Data

Karen Hacker, MD

Family Medicine · Newnan, GANPI 1942392758

Payments from drug & device makers

$3,904in general payments, 2019–2025

Across 234 payments — averaging $16.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$593
  • AbbVie$478
  • Pfizer$366
  • GSK$314
  • Lilly USA, LLC$265
  • Boehringer Ingelheim$243
  • plus $2K from 25 others

What the payments were for

  • Food & beverage$3,904100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,904 in reported general payments places this provider in the 80th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$124,300
Medicare patients
321
Services billed
1,918

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin105$126,010
OzempicSemaglutide73$102,377
TrulicityDulaglutide29$53,455
MounjaroTirzepatide39$48,406
JanuviaSitagliptin Phosphate37$44,141
FarxigaDapagliflozin Propanediol26$29,004
MyrbetriqMirabegron26$26,185
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog53$20,561
Janumet XrSitagliptin Phos/Metformin Hcl17$15,725
RybelsusSemaglutide13$14,174
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$10,018
TrintellixVortioxetine Hydrobromide17$7,894
BelsomraSuvorexant14$6,105
SynthroidLevothyroxine Sodium63$5,800
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,562

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$243$126,010105 claims
Novo NordiskOzempic, Rybelsus$593$116,55186 claims
Lilly USA, LLCTrulicity, Mounjaro$265$101,86168 claims
MerckJanuvia, Janumet Xr, Belsomra$49$65,97168 claims
AstraZenecaFarxiga$225$29,00426 claims
Astellas Pharma US IncMyrbetriq$155$26,18526 claims
GSKAnoro Ellipta, Arnuity Ellipta$314$9,08228 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$18$7,89417 claims
AbbVieSynthroid$478$5,80063 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Newnan

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →